Prof John G Gribben
Professor Gribben specialises in haematological cancers including lymphomas, leukaemias and bone marrow transplantation.
A transfusion means that donated blood is added to your own blood through an intravenous drip into a vein in the arm
3 consultants available
CAR T cell therapy
We use CAR T cell therapy to treat large B-cell lymphoma. This new cancer treatment uses the body’s immune system to kill cancer cells. Find out more today
3 consultants available
Professor John Gribben graduated from the University of Glasgow in 1980. He subsequently trained in Haematology at University College London and in Medical Oncology at the Dana-Farber Cancer Institute, Harvard Medical School, where he remained on the faculty for 17 years before returning to the UK.
He specialises in haematological cancers including lymphomas, leukaemias and bone marrow transplantation.
His NHS post is as Consultant Haematologist and Medical Oncologist Barts and The London NHS Trust.
He is the author of more than 300 articles and chapters in peer-reviewed publications and has a global reputation for his work in researching new drugs and forms of cancer treatment. He has grant funding from The National Cancer Institute and Cancer Research UK for pioneering studies in leukaemia and lymphoma.
He has sat on and chaired numerous international executive committees dedicated to investigating new approaches to cancer care, and several of the editorial boards for professional publications which are focused on cancer. He has lectured across the world on new therapies for cancer treatment.
Professor John G Gribben is available through The London Clinic's Connect service for video consultations.
- Professor and Consultant Medical Oncologist
Barts and The London NHS Trust
- Professor of Experimental Cancer Medicine
Barts and The London School of Medicine, Queen Mary University of London
- University of Glasgow
- University College London
- Harvard Medical School
Middle East Medical Portal
Professor John G Gribben explains why CART-cell therapy has the potential to revolutionise cancer treatment.
Consultant haematologist at The London Clinic on CAR T cell therapy, which has the potential to revolutionise cancer treatment.
Professor Gribben is quoted in this Daily Mail news report on a pioneering immunotherapy treatment.
Professor Gribben's interview with the Marylebone Journal sees him talk stem cells, research and the immune system.